NASDAQ Companies - Bay Street News

NASDAQ Companies - September 29, 2020

FinTech Acquisition Corp. IV Announces Completion of $230,000,000 Initial Public Offering, Including Full Exercise of Over-Allotment Option

PHILADELPHIA, PA, Sept. 29, 2020 (GLOBE NEWSWIRE) — FinTech Acquisition Corp. IV (NASDAQ:FTIVU) (the “Company”), a blank-check company formed for […]

NASDAQ Companies - September 29, 2020

Progress Announces Third Quarter 2020 Financial Results

Revenue Above Top End of Guidance Range Pending Acquisition of Chef Supports Long-Term Growth StrategyBEDFORD, Mass., Sept. 29, 2020 (GLOBE NEWSWIRE) […]

NASDAQ Companies - September 29, 2020

Trustco Bank Makes Significant Investments in New Technologies

GLENVILLE, N.Y., Sept. 29, 2020 (GLOBE NEWSWIRE) — Trustco Bank has rolled out a new online banking platform as well […]

NASDAQ Companies - September 29, 2020

PMV Pharma Announces Closing of $243.5 Million Initial Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares

CRANBURY, N.J., Sept. 29, 2020 (GLOBE NEWSWIRE) — PMV Pharmaceuticals, Inc., a precision oncology company pioneering the discovery and development […]

NASDAQ Companies - September 29, 2020

Prelude Therapeutics Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

WILMINGTON, Del., Sept. 29, 2020 (GLOBE NEWSWIRE) — Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced […]

NASDAQ Companies - September 29, 2020

Tonix Pharmaceuticals Announces Plan to Complete the Phase 3 RELIEF Study of TNX-102 SL for Management of Fibromyalgia with Currently Enrolled Participants Based on Results of Interim Analysis

Topline Results of Full Study Expected Fourth Quarter 2020RELIEF Study Protocol Was Formally Amended Mid-Study to Conform to FDA Guidance […]

NASDAQ Companies - September 29, 2020

FinTech Acquisition Corp. IV Announces Completion of $230,000,000 Initial Public Offering, Including Full Exercise of Over-Allotment Option

Progress Announces Third Quarter 2020 Financial Results

Trustco Bank Makes Significant Investments in New Technologies

PMV Pharma Announces Closing of $243.5 Million Initial Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares

Prelude Therapeutics Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Tonix Pharmaceuticals Announces Plan to Complete the Phase 3 RELIEF Study of TNX-102 SL for Management of Fibromyalgia with Currently Enrolled Participants Based on Results of Interim Analysis

CohBar to Present at the H.C. Wainwright 4th Annual NASH Investor Conference

Encore Capital Group to Announce Third Quarter 2020 Financial Results on November 2

Micron Technology, Inc. Reports Results for the Fourth Quarter and Full Year of Fiscal 2020

Verisk Elects General Vincent Brooks to Board of Directors